Ms Sarah Kupferman > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
![Dechert LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/9038.jpg?v=1653297619)
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Ms Sarah Kupferman
![Sarah Kupferman photo](https://www.legal500.com/wp-content/uploads/sites/13/2020/07/sarah-kupferman-portrait-240x300.jpg)
Work Department
Corporate & Securities
Position
Partner
Career
Sarah Kupferman focuses her practice on corporate and securities matters, counseling private equity and strategic clients on a wide range of domestic and international transactions, including mergers and acquisitions, large and middle market financing transactions, formation of domestic and offshore investment entities and general corporate advice across a variety of industries.
Education
- The George Washington University, B.A., 2009, magna cum laude
- Columbia Law School, J.D., 2012, Harlan Fiske Stone Scholar, Executive Managing Editor of the Columbia Journal of Gender and Law
Top Tier Firm Rankings
- Environment > Environment: transactional
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation